Danske Bank A S trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 734,347 shares of the healthcare conglomerate’s stock after selling 68,163 shares during the period. UnitedHealth Group makes up about 0.5% of Danske Bank A S’s investment portfolio, making the stock its 29th biggest position. Danske Bank A S’s holdings in UnitedHealth Group were worth $269,564,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the stock. City State Bank boosted its holdings in shares of UnitedHealth Group by 5.6% in the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate’s stock valued at $173,000 after purchasing an additional 25 shares during the period. Murphy Pohlad Asset Management LLC increased its holdings in UnitedHealth Group by 0.5% during the 3rd quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate’s stock worth $1,947,000 after purchasing an additional 25 shares during the period. LFG Wealth Partners LLC raised its position in UnitedHealth Group by 3.3% during the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after purchasing an additional 27 shares in the last quarter. Synergy Financial Group LTD lifted its holdings in shares of UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after buying an additional 27 shares during the period. Finally, Ares Financial Consulting LLC grew its position in shares of UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after buying an additional 28 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
More UnitedHealth Group News
Here’s some of the latest news about UNH:
- Positive Sentiment: ETF flows were supportive: 51 ETFs bought UNH while nine sold shares on Nov. 11, for reported net ETF buying of $86.8 million. Article: UnitedHealth Sees $86.8 Million in Net ETF Buying
- Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
- Negative Sentiment: Optum Rx’s prescription volumes declined, highlighting ongoing membership-related pressure even as segment earnings improved. Whether efficiencies and biosimilar adoption can sustain profit growth will matter to investors. Article: Can UNH’s Optum Rx Sustain Profit Growth as Prescription Volumes Fall?
UnitedHealth Group Stock Up 0.6%
Shares of NYSE:UNH traded up $2.49 during trading on Friday, reaching $407.62. The stock had a trading volume of 3,467,004 shares, compared to its average volume of 5,162,694. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a market capitalization of $365.23 billion, a P/E ratio of 23.28, a PEG ratio of 1.47 and a beta of 0.51. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm’s 50-day simple moving average is $391.36 and its 200 day simple moving average is $365.66.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the previous year, the business posted $2.59 EPS. UnitedHealth Group’s revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be issued a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s payout ratio is currently 53.00%.
Insider Activity
In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.19% of the company’s stock.
Wall Street Analyst Weigh In
UNH has been the topic of several research reports. Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Sanford C. Bernstein dropped their target price on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a report on Wednesday, October 14th. HC Wainwright set a $500.00 target price on shares of UnitedHealth Group in a research report on Friday, October 16th. Robert W. Baird reduced their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating for the company in a report on Wednesday, October 14th. Finally, Royal Bank Of Canada upped their price target on shares of UnitedHealth Group from $478.00 to $498.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 20th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $463.93.
Read Our Latest Stock Report on UNH
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Further Reading
- Five stocks we like better than UnitedHealth Group
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
